Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: A case-control study

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Ricker, Lukas J A G ^a,b   Kijlstra, Aize ^a   Kessels, Alfons G H ^a   de Jager, Wilco ^c   Liem, Albert T A ^a   Hendrikse, Fred ^a   la Heij, Ellen C ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b European Graduate School for Neuroscience   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; SCATTER FACTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; INTERLEUKIN DERIVATIVE; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; RETINA DETACHMENT; RHEGMATOGENOUS RETINA DETACHMENT; SCLERA BUCKLING PROCEDURE; SUBRETINAL FLUID; VISUAL ACUITY; VITREORETINOPATHY; BODY FLUID; IMMUNOASSAY; LIMIT OF DETECTION; METABOLISM; METHODOLOGY; MIDDLE AGED; RETINA;

ADULT; AGED; BODY FLUIDS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKINS; LIMIT OF DETECTION; MALE; MIDDLE AGED; RETINA; RETINAL DETACHMENT;

EID: 79955693737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019141     Document Type: Article

References (51)

1. D'Amico DJ, (2008) Clinical practice. Primary retinal detachment. N Engl J Med 359: 2346-2354.
2. Pastor JC, de la Rúa ER, Martín F, (2002) Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 21: 127-144.
3. Fredj-Reygrobellet D, Baudouin C, Nègre F, Caruelle JP, Gastaud P, et al. (1991) Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 23: 154-161.
4. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, et al. (1997) Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 81: 919-926.
5. Spraul CW, Kaven C, Lang GK, Lang GE, (2004) Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation. Ophthalmic Res 36: 166-171.
6. Grant MB, Guay C, Marsh R, (1990) Insulin-like growth factor I stimulates proliferation, migration, and plasminogen activator release by human retinal pigment epithelial cells. Curr Eye Res 9: 323-335.
7. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, et al. (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172: 1535-1545.
8. Kon CH, Occleston NL, Aylward GW, Khaw PT, (1999) Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 40: 705-712.
9. El-Ghrably IA, Dua HS, Orr GM, Fischer D, Tighe PJ, (2001) Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol 85: 461-470.
10. Limb GA, Chignell AH, (1999) Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy. Br J Ophthalmol 83: 953-956.
11. Kauffmann DJH, Van Meurs JC, Mertens DAE, Peperkamp E, Master C, et al. (1994) Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35: 900-906.
12. La Heij EC, Van de Waarenburg MP, Blaauwgeers HG, Kessels AGH, Liem ATA, et al. (2002) Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol 134: 367-375.
13. Wickham L, Bunce C, Wong D, McGurn D, Charteris DG, (2007) Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 114: 698-704.
14. Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, et al. (2008) Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology 115: 1938-1943.
15. Wiedemann P, Hilgers RD, Bauer P, Heimann K, (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126: 550-559.
16. Hollborn M, Francke M, Iandiev I, Bühner E, Foja C, et al. (2008) Early activation of inflammation- and immune response-related genes after experimental detachment of the porcine retina. Invest Ophthalmol Vis Sci 49: 1262-1273.
17. Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, et al. (2006) Characterization of cytokine responses to retinal detachment in rats. Mol Vis 12: 867-878.
18. Canataroglu H, Varinli I, Ozcan AA, Canataroglu A, Doran F, et al. (2005) Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocul Immunol Inflamm 13: 375-381.
19. Su CY, Chen MT, Wu WS, Wu WC, (2000) Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment. J Ocul Pharmacol Ther 16: 463-469.
20. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, et al. (2000) Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol 129: 678-680.
21. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M, (2002) Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Am J Ophthalmol 133: 851-852.
22. Ricker LJAG, Kijlstra A, De Jager W, Liem ATA, Hendrikse H, et al. (2010) Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 51: 4143-4150.
23. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V, (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10: 52.
24. Retina Society Terminology Committee (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90: 121-125.
25. Hosmer DW, Lemeshow S, (1989) Model-building strategies and methods for logistic regression. In: Shewhart WA, Wilks SS, editors. Applied logistic regression New York Wiley pp. 82-134.
26. Mietz H, Heimann K, (1995) Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases. Br J Ophthalmol 79: 874-877.
27. Bali E, Feron EJ, Peperkamp E, Veckeneer M, Mulder PG, et al. (2010) The effect of a preoperative subconjunctival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial. Graefes Arch Clin Exp Ophthalmol 248: 957-962.
28. de Jager W, Te Velthuis H, Prakken BJ, Kuis W, Rijkers GT, (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10: 133-139.
29. Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, et al. (2009) Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 4: e8158.
30. Dieudonné SC, La Heij EC, Diederen R, Kessels AGH, Liem ATA, et al. (2004) High TGF-β2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 45: 4113-4118.
31. Banerjee S, Savant V, Scott RAH, Curnow SJ, Wallace GR, et al. (2007) Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 48: 2203-2207.
32. Rasier R, Gormus U, Artunay O, Yuzbasioglu E, Oncel M, et al. (2010) Vitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachment. Curr Eye Res 35: 505-509.
33. Dieudonné SC, La Heij EC, Diederen RMH, Kessels AGH, Liem ATA, et al. (2007) Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res 39: 148-154.
34. Kirchhof B, Kirchhof E, Ryan SJ, Dixon JF, Barton BE, et al. (1989) Macrophage modulation of retinal pigment epithelial cell migration and proliferation. Graefes Arch Clin Exp Ophthalmol 227: 60-66.
35. Ferrick MR, Thurau SR, Oppenheim MH, Herbort CP, Ni M, et al. (1991) Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci 32: 1534-1539.
36. Kishimoto T, (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8 (Suppl 2): S2.
37. Kuppner MC, McKillop-Smith S, Forrester JV, (1995) TGF-beta and IL-1 beta act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology 84: 265-271.
38. Holtkamp GM, Van Rossem M, de Vos AF, Willekens B, Peek R, et al. (1998) Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol 112: 34-43.
39. de Vos AF, Hoekzema R, Kijlstra A, (1992) Cytokines and uveitis, a review. Curr Eye Res 11: 581-597.
40. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, et al. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6: 315-325.
41. Chong DY, Boehlke CS, Zheng QD, Zhang L, Han Y, et al. (2008) Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 49: 3193-3200.
42. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, et al. (2008) Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors. PLoS ONE 3: e3554.
43. Limb GA, Franks WA, Munasinghe KR, Chignell AH, Dumonde DC, (1993) Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens. Graefes Arch Clin Exp Ophthalmol 231: 331-336.
44. Esser P, Bresgen M, Fischbach R, Heimann K, Wiedemann P, (1995) Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders. Ger J Ophthalmol 4: 269-274.
45. Elner SG, Elner VM, Pavilack MA, Todd RF 3rd, Mayo-Bond L, et al. (1992) Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest 66: 200-211.
46. Frendl G, Beller DI, (1990) Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity. J Immunol 144: 3392-3399.
47. Lindemann A, Mertelsmann R, (1993) Interleukin-3: structure and function. Cancer Invest 11: 609-623.
48. Charteris DG, Hiscott P, Robey HL, Gregor ZJ, Lightman SL, et al. (1993) Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology 100: 43-46.
49. Baudouin C, Hofman P, Brignole F, Bayle J, Loubière R, et al. (1991) Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica 203: 38-46.
50. Gebicke-Haerter PJ, Appel K, Taylor GD, Schobert A, Rich IN, et al. (1994) Rat microglial interleukin-3. J Neuroimmunol 50: 203-214.
51. Lei H, Rheaume MA, Kazlauskas A, (2010) Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. Exp Eye Res 90: 376-381.